Significance of Modified Risk Stratification Msmart 3.0 and Autologous Stem Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma

MLA

Anastasiya Kuzyaeva, et al. “Significance of Modified Risk Stratification Msmart 3.0 and Autologous Stem Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma.” Blood, vol. 134, Nov. 2019, p. 5593. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9e20b1e9048d1905e57d0bddb72c392d&authtype=sso&custid=ns315887.

APA

Anastasiya Kuzyaeva, Alexander Sсhmidt, Alexander Chechetkin, Stanislav Bessmeltcev, Irina Martynkevich, Alexey Kuvshinov, Vasily Shuvaev, Sergei Voloshin, Irina Pavlova, Andrey Garifullin, & Elizaveta Kleina. (2019). Significance of Modified Risk Stratification Msmart 3.0 and Autologous Stem Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma. Blood, 134, 5593.

Chicago

Anastasiya Kuzyaeva, Alexander Sсhmidt, Alexander Chechetkin, Stanislav Bessmeltcev, Irina Martynkevich, Alexey Kuvshinov, Vasily Shuvaev, et al. 2019. “Significance of Modified Risk Stratification Msmart 3.0 and Autologous Stem Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma.” Blood 134 (November): 5593. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9e20b1e9048d1905e57d0bddb72c392d&authtype=sso&custid=ns315887.